VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+1.58%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$79.7M
AUM Growth
+$79.7M
(-89%)
Cap. Flow
-$662M
Cap. Flow
% of AUM
-830.5%
Top 10 Holdings %
Top 10 Hldgs %
21.47%
Holding
291
New
144
Increased
52
Reduced
48
Closed
42
Top Buys
Top Sells
| 1 |
ETP
Energy Transfer Partners, L.P.
ETP
|
$93.5M |
| 2 |
WPZ
Williams Partners L.P.
WPZ
|
$65M |
| 3 |
BPL
Buckeye Partners, L.P.
BPL
|
$48.9M |
| 4 |
Energy Transfer Partners
ET
|
$45.2M |
| 5 |
Enterprise Products Partners
EPD
|
$40.2M |
Sector Composition
| 1 | Healthcare | 70.8% |
| 2 | Financials | 1.05% |
| 3 | Technology | 0.59% |
| 4 | Consumer Discretionary | 0.59% |
| 5 | Consumer Staples | 0.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Fidelity MSCI Information Technology Index ETF
FTEC
$15.1B
| $3.5M | 4.4% | 70,117 +6,700 | +11% | +$335K |
|
2
Vanguard Utilities ETF
VPU
$7.27B
| $2.69M | 3.38% | 23,070 -6,200 | -21% | -$723K |
|
3
iShares 20+ Year Treasury Bond ETF
TLT
$47.8B
| $1.99M | 2.5% | 15,689 +10,800 | +221% | +$1.37M |
|
4
Vanguard Energy ETF
VDE
$7.42B
| $1.9M | 2.38% | 19,199 +850 | +5% | +$84.1K |
|
5
Direxion Daily Financial Bull 3x Shares
FAS
$2.74B
| $1.6M | 2.01% | 23,453 +2,950 | +14% | +$202K |
|
6
ProShares Ultra Utilities
UPW
$13.2M
| $1.12M | 1.4% | 23,700 +17,900 | +309% | +$842K |
|
7
Exelixis
EXEL
$10.1B
| $1.11M | 1.39% | 36,522 -16,099 | -31% | -$489K |
|
|
ONCE
8
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $1.09M | 1.37% | 21,196 +15,378 | +264% | +$791K |
|
9
Neurocrine Biosciences
NBIX
$13.8B
| $1.06M | 1.33% | 13,652 -9,899 | -42% | -$768K |
|
10
United Therapeutics
UTHR
$13.8B
| $1.05M | 1.32% | 7,098 -854 | -11% | -$126K |
|
|
RDUS
11
DELISTED
Radius Health, Inc.
RDUS
| $1.04M | 1.31% | 32,863 +7,964 | +32% | +$253K |
|
12
Vanda Pharmaceuticals
VNDA
$279M
| $1.03M | 1.29% | 67,813 -6,920 | -9% | -$105K |
|
13
Enanta Pharmaceuticals
ENTA
$180M
| $1.03M | 1.29% | 17,531 -14,704 | -46% | -$863K |
|
14
Vertex Pharmaceuticals
VRTX
$100B
| $1.02M | 1.28% | 6,818 -1,482 | -18% | -$222K |
|
|
CLVS
15
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.02M | 1.27% | 14,929 -1,420 | -9% | -$96.5K |
|
|
MNTA
16
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $1.01M | 1.27% | 72,547 +8,058 | +12% | +$112K |
|
17
Nektar Therapeutics
NKTR
$568M
| $1.01M | 1.27% | 16,891 -39,240 | -70% | -$2.34M |
|
18
Sarepta Therapeutics
SRPT
$1.78B
| $996K | 1.25% | 17,897 -13,336 | -43% | -$742K |
|
|
TSRO
19
DELISTED
TESARO, Inc.
TSRO
| $996K | 1.25% | 12,023 +4,926 | +69% | +$408K |
|
|
ACOR
20
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $991K | 1.24% | 46,214 -13,789 | -23% | -$296K |
|
|
SGEN
21
DELISTED
Seagen Inc. Common Stock
SGEN
| $990K | 1.24% | 18,503 +2,315 | +14% | +$124K |
|
|
PTLA
22
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $989K | 1.24% | 20,318 +11,378 | +127% | +$554K |
|
23
Halozyme
HALO
$8.56B
| $981K | 1.23% | 48,401 -29,953 | -38% | -$607K |
|
24
Ligand Pharmaceuticals
LGND
$3.15B
| $981K | 1.23% | 7,161 -1,786 | -20% | -$245K |
|
|
KERX
25
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $980K | 1.23% | 210,666 +53,601 | +34% | +$249K |
|